The Enterprise Value as of December 2025 (TTM) for Celyad Oncology S.A. (CLYYF) is 8.72M

According to Celyad Oncology S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 8.72M. This represents a change of -46.55% compared to the average of 16.32M of the last 4 quarters.

Celyad Oncology S.A. (CLYYF) Historical Enterprise Value (quarterly & annually)

How has CLYYF Enterprise Value performed in the past?

The mean historical Enterprise Value of Celyad Oncology S.A. over the last ten years is 112.77M. The current 8.72M Enterprise Value has changed 673.71% with respect to the historical average. Over the past ten years (40 quarters), CLYYF's Enterprise Value was at its highest in in the December 2015 quarter at 370.84M. The Enterprise Value was at its lowest in in the June 2010 quarter at 0.

Celyad Oncology S.A. (CLYYF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Celyad Oncology S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celyad Oncology S.A. (CLYYF) Average Enterprise Value

How has CLYYF Enterprise Value performed in the past?

The current Enterprise Value of Celyad Oncology S.A. (CLYYF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Celyad Oncology S.A. (CLYYF) Enterprise Value vs. Peers

How is CLYYF’s Enterprise Value compared to its peers?

Celyad Oncology S.A.’s Enterprise Value is less than ERYTECH Pharma S.A. (0), greater than Molecular Partners AG (3.80M), less than XORTX Therapeutics Inc. (45.71M), greater than Nutriband Inc. (1.45M), less than YS Biopharma Co., Ltd. (48.45M), less than Sonnet BioTherapeutics Holdings, Inc. (631.05M), greater than ZyVersa Therapeutics, Inc. (8.18M), greater than Allarity Therapeutics, Inc. (-526844571.00), greater than Kiromic BioPharma, Inc. (83.65K), less than Claritas Pharmaceuticals, Inc. (13.65M), greater than Intellipharmaceutics International Inc. (923.66K), greater than Metacrine, Inc. (7.21M), greater than ForU Holdings, Inc. (-62299000.00), greater than ChitogenX Inc. (3.15M), greater than Aditxt, Inc. (4.60M), greater than Palisade Bio, Inc. (5.43M), less than Plus Therapeutics, Inc. (258.36M), less than Revelation Biosciences, Inc. (26.98M), greater than Quoin Pharmaceuticals, Ltd. (-6547388.00), greater than Virax Biolabs Group Limited (6.89M), greater than Blue Water Vaccines, Inc. (-1142125.00), greater than Hillstream BioPharma, Inc. (973.71K), greater than Kiora Pharmaceuticals, Inc. (1.93M), greater than null (6.96M),

Build a custom stock screener for Celyad Oncology S.A. (CLYYF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celyad Oncology S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celyad Oncology S.A. (CLYYF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celyad Oncology S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.